Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:59 PM EDT

Bio-Techne (TECH) Intangibles (2009 - 2026)

Bio-Techne (TECH) posted quarterly Intangibles of $895.9 million for Q1 2026, up 101.91% year-over-year from $443.7 million in Q1 2025, and up 167.44% quarter-over-quarter from $335.0 million in Q4 2025.

Analysis

Bio-Techne (TECH) Intangibles (2009 - 2026) Analysis & Trends

Bio-Techne's Intangibles history runs 18 years deep, the most recent figure standing at $895.9 million for Q1 2026.

  • In Q1 2026, Intangibles rose 101.91% year-over-year to $895.9 million; the TTM figure through Mar 2026 stood at $895.9 million (up 101.91% YoY), while the FY2025 annual figure was $365.6 million, up 450.6% from the prior year.
  • Intangibles for Q1 2026 stood at $895.9 million, up from $335.0 million in the prior quarter.
  • The five-year high for Intangibles was $895.9 million in Q1 2026, with the low at $22.7 million in Q1 2022.
  • The 5-year median for Intangibles is $461.1 million (2024), against an average of $399.2 million.
  • Peak annual rise in Intangibles reached 2119.07% in 2024, while the deepest fall reached 87.58% in 2024.
  • Bio-Techne's Intangibles stood at $75.6 million in 2022, then surged by 598.29% to $527.9 million in 2023, then fell by 12.66% to $461.1 million in 2024, then slipped by 27.34% to $335.0 million in 2025, then soared by 167.44% to $895.9 million in 2026.
  • Business Quant data shows TECH's Intangibles at $895.9 million in Q1 2026, $335.0 million in Q4 2025, and $350.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 412.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 266.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 63.28 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 60.96 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 93.49 Mn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn 895.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 895.19 Mn
Mar 31, 2026 895.88 Mn
Dec 31, 2025 897.15 Mn
Sep 30, 2025 896.56 Mn
Jun 30, 2025 997.65 Mn
Mar 31, 2025 1.05 Bn
Dec 31, 2024 461.05 Mn
Sep 30, 2024 486.00 Mn
Jun 30, 2024 507.08 Mn
Mar 31, 2024 526.43 Mn
Dec 31, 2023 550.61 Mn
Sep 30, 2023 578.97 Mn
Jun 30, 2023 534.65 Mn
Mar 31, 2023 553.26 Mn
Dec 31, 2022 567.65 Mn
Sep 30, 2022 585.53 Mn
Jun 30, 2022 531.52 Mn
Mar 31, 2022 551.34 Mn
Dec 31, 2021 569.35 Mn
Sep 30, 2021 615.97 Mn